论文信息 - Robust Overall Survival and Sustained Efficacy Outcomes during Long Term Exposure to Momelotinib in JAK Inhibitor Naïve and Previously JAK Inhibitor Treated Intermediate/High Risk Myelofibrosis Patients - 字舞流文

Robust Overall Survival and Sustained Efficacy Outcomes during Long Term Exposure to Momelotinib in JAK Inhibitor Naïve and Previously JAK Inhibitor Treated Intermediate/High Risk Myelofibrosis Patients

S. Verstovsek | R. Mesa | F. Passamonti | M. McMullin | C. Harrison | D. Mclornan | M. Severinsen | C. Scheid | M. Kowalski | E. Lech-Maranda | D. El Fassi | S. Oh | T. Sacha | B. Andreasson | D. Fassi | B. Xicoy | V. Dubruille | M. Egyed | D. Todorieva-Todorova | Gregg D Smith